Kwality Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | BSE: 539997
₹677.85 18.30 (2.77 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 669.90
High (₹) 687.00
Low (₹) 656.25
Prev. Close (₹) 659.55
Volume 6,649
VWAP (₹) 652.69
ROCE (%) 20.04
Industry P/E 43.95
TTM P/E 23.67
P/B Ratio 3.17
Market Cap (₹) Cr.703.35
Dividend Yield (%)--
EPS (₹) 22.76
ROE10.65%
Sales Growth (%) 22.36
Profit Growth (%)22.49
Day Range
687.00687.00
52 Week Range
405.001,069.95
Historical Returns
Returns (6M)
-12.55 %
Returns (1Y)
53.22 %
Returns (3Y)
75.93 %
Returns (5Y)
2159.5 %
Returns (6M)
-12.55 %
Returns (1Y)
53.22 %
Returns (3Y)
75.93 %
Returns (5Y)
2159.5 %
SWOT Analysis
- Company with (25.33%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 25.33% positive TTM EPS growth
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 49.58
MFI 30.48
ATR 61.37
Commodity Channel Index -123.93
ROC125 -9.64
ROC21 -24.98
Williams %R -94.07
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 686.00 | 719.15 | 740.65 | 664.50 | 631.35 | 609.85 | 576.70 |
Week Ago | 719.36 | 737.68 | 747.36 | 709.68 | 691.36 | 681.68 | 663.36 |
Month Ago | 812.05 | 832.70 | 845.40 | 799.35 | 778.70 | 766.00 | 745.35 |
EMA & SMA
677.85
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 691.82
9 Day 697.38
10 Day 710.70
12 Day 711.57
14 Day 723.84
20 Day 753.79
26 Day 775.37
50 Day 834.62
100 Day 840.88
200 Day 722.53
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 10 Jul, 2023 | ₹316.41 | 1,37,152 | BSE |
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 03 Jul, 2023 | ₹295.10 | 1,50,000 | BSE |
BLUEPEAK CONSULTANCY LLP | bulk | Buy | 03 Jul, 2023 | ₹295.00 | 75,000 | BSE |
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 30 Jun, 2023 | ₹295.38 | 1,04,000 | BSE |
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 26 Jun, 2023 | ₹294.07 | 1,58,564 | BSE |
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 08 Jun, 2023 | ₹295.49 | 1,00,000 | BSE |
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 05 Jun, 2023 | ₹295.19 | 1,00,000 | BSE |
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 19 Jan, 2023 | ₹344.24 | 2,50,000 | BSE |
AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 16 Jan, 2023 | ₹354.41 | 1,50,000 | BSE |
DAR S BUSINESS FINANCE PVT LTD | bulk | Sell | 01 Sept, 2022 | ₹347.50 | 80,155 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
17 Feb, 2024 | ADITYA ARORA | Acquisition | ₹485.31 | 4,919 | BSE |
04 Jul, 2023 | ADITYA ARORA | Acquisition | ₹302.55 | 3,200 | BSE |
30 Jun, 2023 | RAMESH ARORA | Disposal | ₹ | 5,18,810 | BSE |
30 Jun, 2023 | ADITYA ARORA | Acquisition | ₹ | 5,18,810 | BSE |
29 Jun, 2022 | ADITYA ARORA | Acquisition | ₹353.22 | 1,410 | BSE |
24 Jun, 2022 | ADITYA ARORA | Acquisition | ₹ | 25,620 | BSE |
24 Jun, 2022 | SACHIN SETH | Disposal | ₹ | 25,620 | BSE |
26 Feb, 2022 | ADITYA ARORA | Acquisition | ₹445.00 | 5,600 | BSE |
25 Feb, 2022 | ADITYA ARORA | Acquisition | ₹445.00 | 5,600 | BSE |
16 Feb, 2022 | ADITYA ARORA | Acquisition | ₹482.79 | 5,200 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
14 Feb, 2025 | BSE India | Kwality Pharmaceuticals Limited receives product registrartion of Cyclophosphamide 1gm in Mexico |
31 Jan, 2025 | BSE India | Integrated filing (Financial) for the quarter and nine months ended December 31,2024 is enclosed |
31 Jan, 2025 | BSE India | UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024 |
31 Jan, 2025 | BSE India | Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulation, 2015 ('Listing Regulations'), this is to inform your that Board of Directors in its meeting held today i.e., January 31, 2025, have inter-alia, considered and approved the Unaudited Standalone and\r\nConsolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024, along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith. |
21 Jan, 2025 | BSE India | KWALITY PHARMA RECEIVED SFDA APPROVAL FOR ITS GENERAL INJECTABLES AND BETA LACTAM (UNIT 1 & 2 IN AMRITSAR). |
20 Jan, 2025 | BSE India | Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine months ended December 31, 2024 along with Limited Review Report. |
02 Jan, 2025 | BSE India | Kwality Pharmaceuticals Limited receives RCGM Approval to Advance for Pre-Clinical Studies of Erythropoietin. |
27 Nov, 2024 | BSE India | Announcement under Regulation 30(6) of SEBI (LODR) Regulations- Schedule of Analyst/ Investor Meeting |
26 Nov, 2024 | BSE India | Kwality received its first Biological Product Permission for Manufacturing and Sale of PEGylated - Asparaginase |
06 Nov, 2024 | BSE India | KWALITY PHARMA RECEIVED THE APPROVAL FOR LEUPRORELIN ACETATE FOR INJECTABLE SUSPENSION AS A SITE VARIATION FROM GREECE. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 21 Jan, 2025 | 31 Jan, 2025 |
Quarterly Results | -- | 23 Oct, 2024 | 30 Oct, 2024 |
Quarterly Results | -- | 05 Aug, 2024 | 10 Aug, 2024 |
Audited Results | -- | 10 May, 2024 | 23 May, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 06 Feb, 2024 |
Quarterly Results | -- | 18 Oct, 2023 | 04 Nov, 2023 |
Quarterly Results | -- | 03 Aug, 2023 | 10 Aug, 2023 |
Audited Results | -- | 19 May, 2023 | 27 May, 2023 |
Quarterly Results | -- | 08 Feb, 2023 | 14 Feb, 2023 |
Quarterly Results | -- | 09 Nov, 2022 | 14 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Kwality Pharmaceuticals
Kwality Pharmaceuticals is a Public Limited Listed company incorporated on 04/05/1983 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24232PB1983PLC005426 and registration number is 005426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 307.17 Cr. and Equity Capital is Rs. 10.38 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1983
Managing Director
Mr. Ramesh Arora
NSE Symbol
--
Kwality Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Ramesh Arora | Managing Director |
Mrs. Anju Arora | Whole Time Director |
Mrs. Geeta Arora | Whole Time Director |
Mr. Kiran Kumar Verma | Independent Director |
Mr. Pankaj Takkar | Independent Director |
Mr. Ravi Shanker Singh | Independent Director |
Mr. Kartik Kapur | Independent Director |
Mr. Prashanth Vellanki | Independent Director |
Mr. Aditya Arora | WholeTime Director & CFO |
Mr. Ajay Kumar Arora | Whole Time Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Kwality Pharmaceuticals
What is the share price of Kwality Pharmaceuticals?
The share price of Kwality Pharmaceuticals on 13 Mar, 2025 is ₹ 677.85.
What is 52W high and 52W low share price of Kwality Pharmaceuticals?
The highest and lowest 52W share prices of Kwality Pharmaceuticals are ₹ 1069.950 and ₹ 405.000
What is the market cap of Kwality Pharmaceuticals?
The market capitalization of Kwality Pharmaceuticals as of 13 Mar, 2025 is ₹ 703.35 Crores
What is the P/E ratio of Kwality Pharmaceuticals?
The current P/E ratio of Kwality Pharmaceuticals as of 13 Mar, 2025 is 43.95
What is the PB ratio of Kwality Pharmaceuticals?
The PB ratio of Kwality Pharmaceuticals as of 13 Mar, 2025 is 3.17
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)